NORTHERN TRUST CORP - ENVVENO MEDICAL CORPORATION ownership

ENVVENO MEDICAL CORPORATION's ticker is and the CUSIP is 29415J106. A total of 23 filers reported holding ENVVENO MEDICAL CORPORATION in Q1 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of ENVVENO MEDICAL CORPORATION
ValueSharesWeighting
Q3 2023$92,029
+75.0%
17,0740.0%0.00%
Q2 2023$52,588
-34.2%
17,0740.0%0.00%
Q1 2023$79,906
-4.3%
17,074
+4.3%
0.00%
Q4 2022$83,523
-4.0%
16,377
+17.8%
0.00%
Q3 2022$87,000
+64.2%
13,9060.0%0.00%
Q2 2022$53,000
-40.4%
13,9060.0%0.00%
Q1 2022$89,000
-3.3%
13,9060.0%0.00%
Q4 2021$92,00013,9060.00%
Other shareholders
ENVVENO MEDICAL CORPORATION shareholders Q1 2022
NameSharesValueWeighting ↓
ACT CAPITAL MANAGEMENT, LLC 401,200$2,556,0002.70%
KINGDON CAPITAL MANAGEMENT, L.L.C. 219,180$1,396,0000.14%
Perceptive Advisors 781,615$4,978,0000.10%
Kepos Capital LP 50,000$319,0000.02%
ARTHUR M. COHEN & ASSOCIATES, LLC 15,000$96,0000.02%
TWO SIGMA INVESTMENTS, LP 33,372$213,0000.00%
TWO SIGMA ADVISERS, LP 49,600$316,0000.00%
WELLS FARGO & COMPANY/MN 2,045$13,0000.00%
NORTHERN TRUST CORP 13,906$89,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of ENVVENO MEDICAL CORPORATION shareholders